17.4. Analysis.

Comparison 17 BPO/clindamycin versus erythromycin/zinc, Outcome 4 Investigator‐assessed absolute change in non‐inflammatory lesions (long‐term data).

Comparison 17 BPO/clindamycin versus erythromycin/zinc, Outcome 4 Investigator‐assessed absolute change in non‐inflammatory lesions (long‐term data).